Literature DB >> 19204327

Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality.

Dirk Schmidt-Arras1, Sylvia-Annette Böhmer, Sina Koch, Jörg P Müller, Lutz Blei, Hauke Cornils, Reinhard Bauer, Sridhar Korasikha, Christian Thiede, Frank-D Böhmer.   

Abstract

The mechanism of cell transformation by Fms-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia (AML) is incompletely understood. The most prevalent activated mutant FLT3 ITD exhibits an altered signaling quality, including strong activation of the STAT5 transcription factor. FLT3 ITD has also been found partially retained as a high-mannose precursor in an intracellular compartment. To analyze the role of intracellular retention of FLT3 for transformation, we have generated FLT3 versions that are anchored in the perinuclear endoplasmic reticulum (ER) by appending an ER retention sequence containing a RRR (R3) motif. ER retention of R3, but not of corresponding A3 FLT3 versions, is shown by biochemical, fluorescence-activated cell sorting, and immunocytochemical analyses. ER anchoring reduced global autophosphorylation and diminished constitutive activation of ERK1/2 and AKT of the constitutively active FLT3 versions. ER anchoring was, however, associated with elevated signaling to STAT3. Transforming activity of the FLT3 D835Y mutant was suppressed by ER anchoring. In contrast, ER-anchored FLT3 ITD retained STAT5-activating capacity and was transforming in vitro and in vivo. The findings highlight another aspect of the different signaling quality of FLT3 ITD: It can transform cells from an intracellular location.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19204327     DOI: 10.1182/blood-2007-10-121426

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.

Authors:  Jianmin Sun; Malin Pedersen; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

2.  A direct role for Met endocytosis in tumorigenesis.

Authors:  Carine Joffre; Rachel Barrow; Ludovic Ménard; Véronique Calleja; Ian R Hart; Stéphanie Kermorgant
Journal:  Nat Cell Biol       Date:  2011-06-05       Impact factor: 28.824

3.  c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathway.

Authors:  Gaku Oshikawa; Toshikage Nagao; Nan Wu; Tetsuya Kurosu; Osamu Miura
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

4.  Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2013-03-19       Impact factor: 6.603

Review 5.  Differential signaling of Flt3 activating mutations in acute myeloid leukemia: a working model.

Authors:  Perry M Chan
Journal:  Protein Cell       Date:  2011-02-25       Impact factor: 14.870

Review 6.  FLT3-ITD and its current role in acute myeloid leukaemia.

Authors:  Francisco Alejandro Lagunas-Rangel; Venice Chávez-Valencia
Journal:  Med Oncol       Date:  2017-05-03       Impact factor: 3.064

7.  Protein-tyrosine phosphatase DEP-1 controls receptor tyrosine kinase FLT3 signaling.

Authors:  Deepika Arora; Sabine Stopp; Sylvia-Annette Böhmer; Julia Schons; Rinesh Godfrey; Kristina Masson; Elena Razumovskaya; Lars Rönnstrand; Simone Tänzer; Reinhard Bauer; Frank-D Böhmer; Jörg P Müller
Journal:  J Biol Chem       Date:  2011-01-24       Impact factor: 5.157

8.  Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia.

Authors:  Lisa S Chen; Sanjeev Redkar; Pietro Taverna; Jorge E Cortes; Varsha Gandhi
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

9.  Pim-1 kinase as cancer drug target: An update.

Authors:  Yernar Tursynbay; Jinfu Zhang; Zhi Li; Tursonjan Tokay; Zhaxybay Zhumadilov; Denglong Wu; Yingqiu Xie
Journal:  Biomed Rep       Date:  2015-12-24

10.  Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.

Authors:  Christine Bellanné-Chantelot; Barbara Schmaltz-Panneau; Caroline Marty; Odile Fenneteau; Isabelle Callebaut; Séverine Clauin; Aurélie Docet; Gandhi-Laurent Damaj; Thierry Leblanc; Isabelle Pellier; Cécile Stoven; Sylvie Souquere; Iléana Antony-Debré; Blandine Beaupain; Nathalie Aladjidi; Vincent Barlogis; Frédéric Bauduer; Philippe Bensaid; Odile Boespflug-Tanguy; Claire Berger; Yves Bertrand; Liana Carausu; Claire Fieschi; Claire Galambrun; Aline Schmidt; Hubert Journel; Françoise Mazingue; Brigitte Nelken; Thuan Chong Quah; Eric Oksenhendler; Marie Ouachée; Marlène Pasquet; Véronique Saada; Felipe Suarez; Gérard Pierron; William Vainchenker; Isabelle Plo; Jean Donadieu
Journal:  Blood       Date:  2018-06-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.